Comparison of Convective Water Vapor Ablation (Convective Water Vapor Energy, WAVE™) With the Rezum™ System Versus Holmium Laser Enucleation of the Prostate (HoLEP) Versus Bipolar Transurethral Resection of the Prostate (TUR-P) in Patients With Benign Prostatic Syndrome (BPS) - A Randomized Study
Vektor
1 other identifier
interventional
198
0 countries
N/A
Brief Summary
Benign prostatic enlargement (BPH/BPS) is one of the most common benign diseases in adult men. About 50% of men are affected by the age of 50, and between the ages of 70 and 80 the prevalence rises to 70-80%. There are various surgical procedures available for the treatment of BPH. In this study, we are investigating three surgical procedures which, based on the current data, appear to be relatively equivalent; however, additional data are still needed to substantiate this. The aim of this study is to compare the three surgical methods REZUM vs. HoLEP vs. TUR-P for endoscopic transurethral subvesical de-obstruction with regard to both subjective and objective voiding function, as well as improvements in quality of life and sexual function. The goal of the study is to work out the possible advantages and disadvantages for future patient counseling, thereby defining more precisely the role of these surgical procedures within the armamentarium of urology. This is a single-center, randomized, prospective interventional study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Nov 2025
Longer than P75 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2025
CompletedFirst Posted
Study publicly available on registry
October 2, 2025
CompletedStudy Start
First participant enrolled
November 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 15, 2030
November 19, 2025
September 1, 2025
11 months
September 24, 2025
November 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Non-inferiority of the surgical techniques in symptom improvement, determined by the change (delta) in the International Prostate Symptom Score (IPSS) at 1 month compared to baseline IPSS.
1 month
Study Arms (3)
TURP
ACTIVE COMPARATORHOLEP
ACTIVE COMPARATORREZUM
ACTIVE COMPARATORInterventions
We compare 3 different types of BPH surgery - HoLEP vs. TURP vs. REZUM
Eligibility Criteria
You may qualify if:
- Age \> 18 years
- Patients with confirmed benign prostatic syndrome for whom surgical therapy is indicated
- Prostate volume between 30 and 80 ml
You may not qualify if:
- Lack of capacity to give informed consent
- Emergency surgeries
- Known prostate carcinoma
- Elevated post-void residual urine \> 300 ml
- Neurogenic bladder emptying disorder
- Urethral pathologies
- High-intensity anticoagulation
- Dual antiplatelet therapy
- History of pelvic radiation
- Chronic pelvic pain syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2025
First Posted
October 2, 2025
Study Start
November 15, 2025
Primary Completion (Estimated)
October 15, 2026
Study Completion (Estimated)
October 15, 2030
Last Updated
November 19, 2025
Record last verified: 2025-09